Dr Reddys Laboratories Ltd Stock: price and insider trades · United States
Dr Reddys Laboratories Ltd: what insiders have been doing
Only a handful of insider records exist for Dr Reddys Laboratories Ltd, the last one from 2 November 2026, too few to describe a trend. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Dr Reddys Laboratories Ltd Buy (bullish), based on 5 analysts. Average price target: US$14.34.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 460,726 shares@ US$14.20100.0% of flowRDY (DR REDDYS LABORATORIES LTD SPONSORED ADR)SEC144:0001628280-26-068742
1 of 1 declaration
About Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded medications. It is listed on NASDAQ under the symbol RDY.
